Global Electrical Bone Growth Stimulators Market Size By Product (External Type, Implanted Type), By Application (Hospitals And Clinics, Home Care, Academic And Research Institutes), By Geographic Scope And Forecast

Electrical Bone Growth Stimulators Market Size And Forecast

Electrical Bone Growth Stimulators Market size was valued at USD 2.04 Billion in 2022 and is projected to reach USD 3.3 Billion by 2030 , growing at a CAGR of 5.3% from 2023 to 2030. The growing preference for non-invasive and minimally invasive surgical treatments is the crucial aspect of the rise in the market revenue of Electrical Bone Growth Stimulators, and the increasing target patient population will foster market growth. The Global Electrical Bone Growth Stimulators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electrical Bone Growth Stimulators Market Definition

Bone growth stimulator (BGS) is a device utilized in the medical industry for the healing process of a fracture. BGS enhances this process by stimulating the assembly of the latest cells by applying the right amount of electricity to the bone, allowing the fracture to heal considerably faster. Stimulators are usually employed for hard-to-treat fractures, nonunions, and inadequately healing stress fractures of the scaphoid, distal tibia, femur, humerus, and fifth metatarsal shaft.

The bone growth stimulation leads to an enhanced osteogenic environment with calcification and mineralization of the fibrocartilage repairs the fracture site and improves vascularity. Although a healthcare provider's understanding that bone healing could also be complicated or impaired would seemingly justify the utilization of a bone stimulator, the existing research has not illustrated that the utilization of a bone stimulator under certain circumstances is effective.

Global Electrical Bone Growth Stimulators Market Overview

The rise in obesity and hence the increase in the number of orthopedic injuries are the main driving factors for the expansion of the Electrical Bone Growth Stimulators Market. The rise in non-invasive medical practices to reinforce the success of bone grafting procedures and the low risk of adverse effects also are expected to accelerate the demand for BGS. The complexity rates in BGS are low as compared to other invasive medical treatment techniques.

The rapid rise in automobile users also leads to a substantial rise in road accidents resulting in spinal injuries and therefore eventually promoting the expansion of the Electrical Bone Growth Stimulators Market. However, inadequate knowledge about the success rates of BGS and therefore the higher treatment cost are the main restraints within the growth of the bone growth stimulator. Moreover, the increasing demand for safe, innovative, and modern effective treatment techniques can create a chance for the Electrical Bone Growth Stimulators Market.

Global Electrical Bone Growth Stimulators Market: Segmentation Analysis

The Global Electrical Bone Growth Stimulators Market is Segmented on the basis of Product, Application, And Geography.

Electrical Bone Growth Stimulators Market, By Product

• External Type
• Implanted Type

Based on Product, the market is bifurcated into External Type and Implanted Type. The external type segment is expected to account for the largest market share in the estimated period. This can primarily be attributed to the growing aging population globally, the rising preference for non-surgical treatment procedures, and therefore the growing prevalence of nonunion fractures.

Electrical Bone Growth Stimulators Market, By Application

• Hospitals and Clinics
• Home Care
• Academic and Research Institutes

Based on Application, the market is bifurcated into Hospitals and Clinics, Home Care, and Academic and Research Institutes. The hospitals and clinics segment accounted for the most important of the market. The advantages of bone growth stimulation products over their counterparts are the key factor driving their adoption during this end-user segment.

Electrical Bone Growth Stimulators Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, The Global Electrical Bone Growth Stimulators Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The U.S. drives the expansion within the North American region as it is the largest market within the region. The Asia-Pacific region offers considerable potential for market growth attributable to the rapid climb in markets such as India and China. The APAC region is projected to experience growth at the highest CAGR.

Key Players

• The "Global Electrical Bone Growth Stimulators Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Stryker, ITO, Orthofix Medical, Zimmer Biomet.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Partnerships, Collaborations and Agreements
• In April 2021, Orthofix Medical Inc., an international medical device firm, announced that it has entered into a formal license deal to commercialize the revolutionary portfolio of IGEA S.p. A's bone and soft tissue stimulation products in the United States and Canada. With this agreement, the firm gains the authority to obtain US Food and Drug Administration clearances for IGEA's orthopedic product platform.
• Orthofix signed an exclusive license agreement in 2021 to commercialize IGEA's revolutionary array of bone, cartilage, and soft tissue stimulation solutions in the United States and Canada.
• DePuy Synthes renewed its cooperation with the AO Foundation in 2020 to improve patient care and outcomes through innovation and the AO Foundation's independent worldwide education initiatives.
• Mergers and Acquisitions
• Stryker paid USD 5.4 billion for Wright Medical in 2020. Stryker's position in the orthopedics device industry was reinforced as a result of the acquisition.
• Medtronic plc announced in January 2020 that it had acquired Stimgenics, LLC, a privately held business that has developed a unique spinal cord stimulation (SCS) therapy. This therapy is given via the Medtronic Intellis platform and is a new and exclusive programming option for treating chronic pain patients.
• In February 2019, Colfax Corporation paid $3.15 billion to acquire DJO Global Inc. from an investment group led by private equity funds managed by Blackstone. With this acquisition, Colfax Corporation intends to achieve significant development in the orthopedic solutions industry.
• Product Launches and Product Expansions
• Orthofix Medical Inc., a medical device firm, announced the FDA approval of the STIM Ontrack mobile app version to be utilized by the company's bone growth stimulators in February 2020. This technology works in conjunction with the Orthofix bone growth therapy devices to help patients adhere to their prescriptions and advance their clinical results.
• Orthofix International N.V. releases its next-generation bone growth stimulators, Cervical-Stim and Spinal-Stim, in April 2017. These gadgets are intended to encourage and boost the body's natural healing process following a spinal fusion operation.